These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30679805)

  • 21. Phenome-driven disease genetics prediction toward drug discovery.
    Chen Y; Li L; Zhang GQ; Xu R
    Bioinformatics; 2015 Jun; 31(12):i276-83. PubMed ID: 26072493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Planning in the context of a virtuous cycle for tuberculosis vaccine development.
    Small PM
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S4-5. PubMed ID: 22441159
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic approaches to studying mouse models of human seizure disorders.
    Yang Y; Frankel WN
    Adv Exp Med Biol; 2004; 548():1-11. PubMed ID: 15250582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine models of psoriasis and their usefulness for drug discovery.
    Chuang SY; Lin CH; Sung CT; Fang JY
    Expert Opin Drug Discov; 2018 Jun; 13(6):551-562. PubMed ID: 29663834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering Xenopus embryos for phenotypic drug discovery screening.
    Schmitt SM; Gull M; Brändli AW
    Adv Drug Deliv Rev; 2014 Apr; 69-70():225-46. PubMed ID: 24576445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets.
    Bogenpohl JW; Mignogna KM; Smith ML; Miles MF
    Methods Mol Biol; 2017; 1488():531-549. PubMed ID: 27933543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of systemic lupus erythematosus: contributions of mouse models in the era of human genome-wide association studies.
    Xu Z; Morel L
    Discov Med; 2010 Jul; 10(50):71-8. PubMed ID: 20670601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.
    Fenske RJ; Kimple ME
    Exp Biol Med (Maywood); 2018 Mar; 243(6):586-591. PubMed ID: 29504478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.
    Löscher W
    Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding atherosclerosis through mouse genetics.
    Sheth SS; Deluna A; Allayee H; Lusis AJ
    Curr Opin Lipidol; 2002 Apr; 13(2):181-9. PubMed ID: 11891421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Discovery and Validation of Drug Targets Through Human Genetics and Epigenetics.
    Stankov K
    Curr Pharm Des; 2017; 23(1):3-4. PubMed ID: 28292247
    [No Abstract]   [Full Text] [Related]  

  • 32. Priority index for human genetics and drug discovery.
    Plenge RM
    Nat Genet; 2019 Jul; 51(7):1073-1075. PubMed ID: 31253975
    [No Abstract]   [Full Text] [Related]  

  • 33. Human genetic individuality.
    Olson MV
    Annu Rev Genomics Hum Genet; 2012; 13():1-27. PubMed ID: 22657391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation.
    Yoganantharjah P; Gibert Y
    Curr Top Med Chem; 2017; 17(18):2041-2055. PubMed ID: 28137236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding hypertension through genetic manipulation in mice.
    Cvetkovic B; Sigmund CD
    Kidney Int; 2000 Mar; 57(3):863-74. PubMed ID: 10720939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The autoimmune contrivance: genetics in the mouse model.
    Melanitou E
    Clin Immunol; 2005 Dec; 117(3):195-206. PubMed ID: 16188504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DiGeorge syndrome: the use of model organisms to dissect complex genetics.
    Baldini A
    Hum Mol Genet; 2002 Oct; 11(20):2363-9. PubMed ID: 12351571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic architecture of schizophrenia: new mutations and emerging paradigms.
    Rodriguez-Murillo L; Gogos JA; Karayiorgou M
    Annu Rev Med; 2012; 63():63-80. PubMed ID: 22034867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.